Other Species / Isoforms
  SOCS3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K6-ub
__MVTHSkFPAAGMS
Downstream
1 0
Effects on Modified Protein
  • protein degradation
SOCS3 (human) __MVTHSkFPAAGMS K6-ub
SOCS3 (mouse) __MVTHSKFPAAGMS K6
SOCS3 (rat) __MVTHSKFPAAGMS K6
K23-ub
LDTSLRLkTFSSKSE
0 1
SOCS3 (human) LDTSLRLkTFSSKSE K23-ub
SOCS3 (mouse) LDTSLRLKTFSSKSE K23
SOCS3 (rat) LDTSLRLKTFSSKSE K23
T86-p
FFTLSVKtQSGTKNL
0 1
SOCS3 (human) FFTLSVKtQSGTKNL T86-p
SOCS3 (mouse) FFTLSVKTQSGTKNL T86
SOCS3 (rat) FFTLSVETQSGTKNL T86
Y165-p
GSPPRRAyyIYSGGE
0 1
SOCS3 (human) GSPPRRAyyIYSGGE Y165-p
SOCS3 (mouse) GSTPKRAYYIYSGGE Y165
SOCS3 (rat) GGTPKRAYYIYSGGE Y165
Y166-p
SPPRRAyyIYSGGEK
0 1
SOCS3 (human) SPPRRAyyIYSGGEK Y166-p
SOCS3 (mouse) STPKRAYYIYSGGEK Y166
SOCS3 (rat) GTPKRAYYIYSGGEK Y166
K195-ub
TLQHLCRkTVNGHLD
0 1
SOCS3 (human) TLQHLCRkTVNGHLD K195-ub
SOCS3 (mouse) TLQHLCRKTVNGHLD K195
SOCS3 (rat) TLQHLCRKTVNGHLD K195
Y204-p
VNGHLDSyEkVTQLP
Upstream
Downstream
5 13
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • Lck (human)
Putative in vivo kinases:
  • JAK2 (human)
Treatment
  • cycloheximide
  • EGF
  • IL-10
  • imatinib
  • LPS
  • vanadate
SOCS3 (human) VNGHLDSyEkVTQLP Y204-p
SOCS3 (mouse) VNGHLDSyEKVTQLP Y204-p
SOCS3 (rat) VNGHLDSYEKVTQLP Y204
K206-ub
GHLDSyEkVTQLPGP
0 1
SOCS3 (human) GHLDSyEkVTQLPGP K206-ub
SOCS3 (mouse) GHLDSyEKVTQLPGP K206
SOCS3 (rat) GHLDSYEKVTQLPGP K206
Y221-p
IREFLDQyDAPL___
Upstream
Downstream
4 0
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • Lck (human)
Putative in vivo kinases:
  • JAK2 (human)
Treatment
  • cycloheximide
  • EGF
  • LPS
  • PDGF
  • vanadate
SOCS3 (human) IREFLDQyDAPL___ Y221-p
SOCS3 (mouse) IREFLDQyDAPL___ Y221-p
SOCS3 (rat) IREFLDQYDAPL___ Y221